Wendy future of retail top

Opioid Withdrawal Syndrome

US WorldMeds and Salix announce U.S. roll out of Lucemyra

US WorldMeds and Salix announce U.S. roll out of Lucemyra

LOUISVILLE, K.Y. and BIDGEWATER, N.J. – US WorldMeds, LLC, and Salix Pharmaceuticals, a wholly owned subsidiary of Bausch Health Companies Inc., today announced the U.S. launch and availability of Lucemyra (lofexidine) 0.18 mg tablets, the first and only non-opioid medication indicated for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults. The Centers

PP_1170x120_10-25-21